Literature DB >> 33812912

First experience of autonomous, un-supervised treatment planning integrated in adaptive MR-guided radiotherapy and delivered to a patient with prostate cancer.

Luise A Künzel1, Marcel Nachbar2, Markus Hagmüller2, Cihan Gani3, Simon Boeke3, Daniel Zips4, Daniela Thorwarth5.   

Abstract

BACKGROUND AND
PURPOSE: Currently clinical radiotherapy (RT) planning consists of a multi-step routine procedure requiring human interaction which often results in a time-consuming and fragmented process with limited robustness. Here we present an autonomous un-supervised treatment planning approach, integrated as basis for online adaptive magnetic resonance guided RT (MRgRT), which was delivered to a prostate cancer patient as a first-in-human experience.
MATERIALS AND METHODS: For an intermediate risk prostate cancer patient OARs and targets were automatically segmented using a deep learning-based software and logical volume operators. A baseline plan for the 1.5 T MR-Linac (20x3 Gy) was automatically generated using particle swarm optimization (PSO) without any human interaction. Plan quality was evaluated by predefined dosimetric criteria including appropriate tolerances. Online plan adaptation during clinical MRgRT was defined as first checkpoint for human interaction.
RESULTS: OARs and targets were successfully segmented (3 min) and used for automatic plan optimization (300 min). The autonomous generated plan satisfied 12/16 dosimetric criteria, however all remained within tolerance. Without prior human validation, this baseline plan was successfully used during online MRgRT plan adaptation, where 14/16 criteria were fulfilled. As postulated, human interaction was necessary only during plan adaptation.
CONCLUSION: Autonomous, un-supervised data preparation and treatment planning was first-in-human shown to be feasible for adaptive MRgRT and successfully applied. The checkpoint for first human intervention was at the time of online MRgRT plan adaptation. Autonomous planning reduced the time delay between simulation and start of RT and may thus allow for real-time MRgRT applications in the future.
Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Artificial intelligence; Automatic segmentation; Autonomous radiotherapy planning; MR-Linac; MR-guided radiotherapy; Particle swarm optimization

Year:  2021        PMID: 33812912     DOI: 10.1016/j.radonc.2021.03.032

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  5 in total

1.  Automated Planning for Prostate Stereotactic Body Radiation Therapy on the 1.5 T MR-Linac.

Authors:  Stefania Naccarato; Michele Rigo; Roberto Pellegrini; Peter Voet; Hafid Akhiat; Davide Gurrera; Antonio De Simone; Gianluisa Sicignano; Rosario Mazzola; Vanessa Figlia; Francesco Ricchetti; Luca Nicosia; Niccolò Giaj-Levra; Francesco Cuccia; Nadejda Stavreva; Dobromir S Pressyanov; Pavel Stavrev; Filippo Alongi; Ruggero Ruggieri
Journal:  Adv Radiat Oncol       Date:  2022-02-12

2.  Evaluation of an automated template-based treatment planning system for radiotherapy of anal, rectal and prostate cancer.

Authors:  Lucie Calmels; Patrik Sibolt; Lina M Åström; Eva Serup-Hansen; Henriette Lindberg; Anna-Lene Fromm; Gitte Persson; David Sjöström; Poul Geertsen; Claus P Behrens
Journal:  Tech Innov Patient Support Radiat Oncol       Date:  2022-04-12

3.  Technical feasibility of online adaptive stereotactic treatments in the abdomen on a robotic radiosurgery system.

Authors:  Maaike T W Milder; Alba Magallon-Baro; Wilhelm den Toom; Erik de Klerck; Lorne Luthart; Joost J Nuyttens; Mischa S Hoogeman
Journal:  Phys Imaging Radiat Oncol       Date:  2022-07-28

4.  Clinical rationale for in vivo portal dosimetry in magnetic resonance guided online adaptive radiotherapy.

Authors:  Begoña Vivas Maiques; Igor Olaciregui Ruiz; Tomas Janssen; Anton Mans
Journal:  Phys Imaging Radiat Oncol       Date:  2022-06-11

Review 5.  [Primary treatment of prostate cancer using 1.5 T MR-linear accelerator].

Authors:  Daniel Wegener; Daniel Zips; Cihan Gani; Simon Boeke; Konstantin Nikolaou; Ahmed E Othman; Haidara Almansour; Frank Paulsen; Arndt-Christian Müller
Journal:  Radiologe       Date:  2021-07-23       Impact factor: 0.635

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.